With the continuous development of the medical aesthetics industry, the demand for dermal fillers continues to grow, especially in applications that pursue long-term effectiveness and biocompatibility. Polymethyl methacrylate (PMMA) has become a highly regarded material due to its excellent stability and durability. BOC Sciences focuses on the research and development and manufacturing of polymer materials and biomedical formulations, offering a full range of services to the medical aesthetics industry, including PMMA microsphere preparation, composite carrier optimization, injectable formulation development, GMP-level production, and quality control. We are dedicated to assisting clients in developing high-quality, long-lasting, safe, and reliable PMMA dermal fillers through scientifically rigorous formulation processes.
Polymethyl methacrylate (PMMA) is a non-degradable synthetic polymer material that exhibits good biocompatibility, physical stability, and shape retention. As a permanent soft tissue filler, PMMA is used in microsphere form combined with a carrier (such as bovine collagen) to form an injectable formulation. After injection, PMMA fillers achieve long-lasting filling and contour restoration through collagen degradation and tissue regeneration. The mechanism of action of PMMA fillers primarily involves physical filling and the stimulation of collagen regeneration. Specifically, the microspheres in PMMA fillers form a scaffold after injection, providing physical filling that immediately restores tissue volume and fills wrinkles and depressed areas. At the same time, PMMA microspheres stimulate the host's immune response, attracting immune cells such as macrophages, which promote collagen deposition and tissue regeneration. This dual-action mechanism allows PMMA fillers to not only improve the appearance of the skin quickly but also maintain the filling effect in the long term, offering durability. Currently, PMMA fillers are used in dermal contour reshaping, depression repair, wrinkle smoothing, and acne scar treatment, among other areas. In addition, the U.S. FDA has approved its use for nasolabial folds, deep dermal and neck wrinkles, and atrophic scars.
Accurately control the particle size of PMMA microspheres to ensure smooth injection and natural tissue integration.
Support for a variety of biological carrier formulations to enhance the biocompatibility and viscoelastic properties of the formulation.
Customizable additives such as anesthetics and preservatives to enhance user comfort and safety.
Use pharmacopeia-grade PMMA materials, strictly controlling impurity and residual monomer content.
Equipped with clean workshops and filling equipment to meet high-level sterile production requirements.
From small-scale development to pilot production, meeting the development needs at different stages.
Provide full-process testing for particle size, viscosity, sterility, etc., to ensure batch consistency.
Our team of medical aesthetics formulation experts and materials scientists support fast and efficient project advancement.
BOC Sciences is committed to providing efficient, safe, and sustainable PMMA dermal filler development solutions for medical aesthetics companies. Relying on materials science, biopharmaceutical engineering, and GMP production platforms, we have established a complete integrated service process, covering every critical stage from custom PMMA microspheres, high-performance carrier screening and preparation, formulation blending, functional excipient addition, packaging sterilization, to quality testing and product release. Our services not only ensure seamless transition from small-scale trials to commercialization but also meet client needs in performance optimization, regulatory compliance, and market differentiation, helping clients quickly and efficiently complete medical aesthetic product development and market launch.
Using advanced suspension polymerization technology, control the microsphere particle size within the range of 30–50μm, ensuring spherical shape, smooth surface, and effective prevention of particle aggregation, thus improving injection compliance and tissue integration capability.
Based on clinical safety and functional requirements, provide a variety of natural and synthetic carrier options such as gelatin, collagen, HPMC, and CMC-Na, optimizing the gel's mechanical properties, viscoelasticity, and in vivo metabolism behavior.
Prepare physically stable, appropriately viscous carrier solutions in a GMP-standard environment through temperature-controlled stirring, pH adjustment, and sterile filtration processes, ensuring uniform dispersion of microspheres and smooth injection feel.
Using high-shear mixing and ultrasonic treatment technology, PMMA microspheres are stably dispersed in the carrier system, effectively preventing sedimentation, aggregation, and nozzle blockage, ensuring smooth injection of the filler.
Based on customer needs and regulatory requirements, quantitatively add excipients such as lidocaine hydrochloride, sodium chloride, and phosphate buffer solution to enhance analgesic, preservative, and osmotic balance properties, improving product comfort and safety.
In a cleanroom environment of class 100,000 or 10,000, automated equipment is used for efficient filling and capping, supporting various packaging specifications such as pre-filled syringes and glass vials, ensuring sterile conditions and production efficiency.
Choose from ethylene oxide, γ-ray, or moist heat sterilization methods for different formulations and packaging materials, ensuring stability of active ingredients while meeting sterilization requirements in compliance with international regulatory standards.
BOC Sciences has modern production facilities that meet international GMP standards, specializing in pilot-scale and commercial manufacturing of high-quality aesthetic medical products. Our production workshops are equipped with cleanroom environments at the 100,000-level and fully automated sterile filling lines, capable of mass production of PMMA fillers in various specifications, including pre-filled syringes, ampoules, or other customized packaging formats. We adhere to a strict GMP quality control system throughout the entire process, from raw material inspection, environmental monitoring, key process control, to final product release. Each step is governed by rigorous operational standards and record-keeping systems, ensuring batch-to-batch consistency and traceability. Our professional production team and quality management department are flexible in adjusting production capacity, accommodating both early-stage R&D pilot production and large-scale commercial production. BOC Sciences is dedicated to helping clients quickly advance product registration and market launch, meeting the global aesthetic medical market's requirements for safety, stability, and regulatory compliance.
BOC Sciences is committed to providing comprehensive quality testing services to ensure that each batch of PMMA filler meets stringent quality standards at every stage of production. We possess advanced testing equipment and a team of experienced quality management professionals, executing comprehensive quality control from raw materials to finished products. All products undergo a series of precision tests to ensure compliance with GMP and relevant regulatory requirements. Our testing services cover key indicators such as microsphere particle size, rheology, sterility, and stability, ensuring that each batch of filler meets safety, stability, and performance requirements. Through our well-established testing procedures, we guarantee product quality consistency and provide clients with detailed quality reports and compliance support, assisting them in gaining certification and trust in global markets.
PMMA fillers, with their durability, non-degradability, and high biocompatibility, are widely used in the medical aesthetics field. As a permanent soft tissue filler, PMMA fillers play an important role in dermal reshaping, wrinkle repair, scar treatment, and many other areas. Their unique physicochemical properties provide distinct advantages in improving dermal contours, restoring skin elasticity, and adding dermal volume. PMMA fillers offered by BOC Sciences, after strict quality control and optimization, meet the high standards required by the aesthetic medical industry for durability, safety, and effectiveness, helping doctors and patients achieve long-term satisfaction with cosmetic results.
PMMA fillers typically provide long-lasting results. Since PMMA microspheres are not absorbed by the body and do not degrade, the filling effect can last for years, even reaching permanence. Generally, the filling effect is gradually replaced by collagen within 3 to 6 months after injection, ultimately maintaining a lasting filling effect. The exact duration may vary depending on individual factors, but the effect of PMMA fillers typically lasts from 5 to 10 years.
Yes, PMMA injections are generally considered permanent. PMMA microspheres are not absorbed by the body and do not degrade over time, making the filling effect long-term or even permanent in most cases. After injection, PMMA microspheres are gradually encased by newly generated collagen, eventually fusing with connective tissue to form a stable filling structure that provides long-lasting aesthetic effects.
PMMA fillers are widely used in dermal aesthetics and plastic surgery. They are commonly used to improve dermal wrinkles, depressions, and volume loss, such as nasolabial folds, marionette lines, and cheek hollows. Additionally, PMMA fillers can be used for acne scar repair, nasal reshaping, chin and cheekbone contouring, and more. Due to their durability, PMMA is an effective and long-lasting filling material that provides patients with long-term aesthetic results.
PMMA is considered safe in medical aesthetics, though some risks may still exist. Since PMMA microspheres are not absorbed and provide permanent filling effects, they do not typically cause allergic or rejection reactions. After rigorous quality control, PMMA fillers are generally FDA-approved. However, temporary redness, swelling, bruising, or allergic reactions may occur during PMMA injections, so it is recommended that injections be performed by professional doctors to ensure safety.
Current research indicates that PMMA itself does not cause cancer. PMMA microspheres are a biocompatible material and generally do not produce toxicity or carcinogenic effects in the body. However, any external injectable substance may carry risks during injection, especially if improperly administered or if non-compliant materials are used. To date, clinical evidence regarding the carcinogenicity of PMMA is insufficient, and it is considered relatively safe. Nonetheless, caution is advised, and patients should choose certified products and qualified medical professionals for injection.